These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37149476)

  • 1. Pholcodine, perioperative anaphylaxis, and the European Medicines Agency: finally the decision to remove pholcodine from the market in the European Union.
    Florvaag E; Johansson G
    Br J Anaesth; 2023 Jul; 131(1):11-13. PubMed ID: 37149476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pholcodine exposure increases the risk of perioperative anaphylaxis to neuromuscular blocking agents: the ALPHO case-control study.
    Mertes PM; Petitpain N; Tacquard C; Delpuech M; Baumann C; Malinovsky JM; Longrois D; Gouel-Cheron A; Le Quang D; Demoly P; Guéant JL; Gillet P;
    Br J Anaesth; 2023 Jul; 131(1):150-158. PubMed ID: 36967281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation between pholcodine and perioperative anaphylaxis].
    Dumancić J; Marković AS
    Acta Med Croatica; 2012 May; 66(2):111-4. PubMed ID: 23437637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pholcodine exposure raises serum IgE in patients with previous anaphylaxis to neuromuscular blocking agents.
    Harboe T; Johansson SG; Florvaag E; Oman H
    Allergy; 2007 Dec; 62(12):1445-50. PubMed ID: 17983379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship of perioperative anaphylaxis to neuromuscular blocking agents, obesity, and pholcodine consumption: a case-control study.
    Sadleir PHM; Clarke RC; Goddard CE; Day C; Weightman W; Middleditch A; Platt PR
    Br J Anaesth; 2021 May; 126(5):940-948. PubMed ID: 33454050
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Six years without pholcodine; Norwegians are significantly less IgE-sensitized and clinically more tolerant to neuromuscular blocking agents.
    de Pater GH; Florvaag E; Johansson SG; Irgens Å; Petersen MN; Guttormsen AB
    Allergy; 2017 May; 72(5):813-819. PubMed ID: 27859358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exploring the link between pholcodine exposure and neuromuscular blocking agent anaphylaxis.
    Brusch AM; Clarke RC; Platt PR; Phillips EJ
    Br J Clin Pharmacol; 2014 Jul; 78(1):14-23. PubMed ID: 24251966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pholcodine consumption and immunoglobulin E-sensitization in atopics from Australia, Korea, and Japan.
    Katelaris CH; Kurosawa M; Moon HB; Borres M; Florvaag E; Johansson SG
    Asia Pac Allergy; 2014 Apr; 4(2):86-90. PubMed ID: 24809013
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of pholcodine-specific IgE in addition to morphine-specific IgE improves investigation of neuromuscular blocking agent anaphylaxis.
    Anderson J; Green S; Capon M; Krupowicz B; Li J; Fulton R; Fernando SL
    Br J Anaesth; 2020 Dec; 125(6):e450-e452. PubMed ID: 32600804
    [No Abstract]   [Full Text] [Related]  

  • 10. Pholcodine in cough medicines and IgE-sensitization in the EU: an urgent task.
    Florvaag E; Johansson SG
    Allergy; 2012 May; 67(5):581-2. PubMed ID: 22380984
    [No Abstract]   [Full Text] [Related]  

  • 11. IgE-sensitization to the cough suppressant pholcodine and the effects of its withdrawal from the Norwegian market.
    Florvaag E; Johansson SG; Irgens Å; de Pater GH
    Allergy; 2011 Jul; 66(7):955-60. PubMed ID: 21241314
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pholcodine and allergy to neuromuscular blocking agents: where are we and how did we get here?
    Savic L; Hopkins PM
    Br J Anaesth; 2024 Mar; 132(3):457-460. PubMed ID: 38071149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morphine and pholcodine-specific IgE have limited utility in the diagnosis of anaphylaxis to benzylisoquinolines.
    Rose MA; Anderson J; Green SL; Yun J; Fernando SL
    Acta Anaesthesiol Scand; 2018 May; 62(5):628-634. PubMed ID: 29368335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New insights into the role of pholcodine in the treatment of cough in 2013?].
    Blanchard E; Tunon de Lara M
    Therapie; 2013; 68(2):85-91. PubMed ID: 23773349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Anaphylaxis during anaesthesia].
    Guttormsen AB; Harboe T; Pater Gd; Florvaag E
    Tidsskr Nor Laegeforen; 2010 Mar; 130(5):503-6. PubMed ID: 20224620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pholcodine story.
    Florvaag E; Johansson SG
    Immunol Allergy Clin North Am; 2009 Aug; 29(3):419-27. PubMed ID: 19563989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypersensitivity reactions to neuromuscular blocking agents.
    Mertes PM; Aimone-Gastin I; Guéant-Rodriguez RM; Mouton-Faivre C; Audibert G; O'Brien J; Frendt D; Brezeanu M; Bouaziz H; Guéant JL
    Curr Pharm Des; 2008; 14(27):2809-25. PubMed ID: 18991700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromuscular blocking agents induced anaphylaxis: Results and trends of a French pharmacovigilance survey from 2000 to 2012.
    Petitpain N; Argoullon L; Masmoudi K; Fedrizzi S; Cottin J; Latarche C; Mertes PM; Gillet P;
    Allergy; 2018 Nov; 73(11):2224-2233. PubMed ID: 29654608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Not Available].
    Blanchard E; de Lara MT
    Therapie; 2013; 68(2):85-91. PubMed ID: 27392673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reclassifying Anaphylaxis to Neuromuscular Blocking Agents Based on the Presumed Patho-Mechanism: IgE-Mediated, Pharmacological Adverse Reaction or "Innate Hypersensitivity"?
    Spoerl D; Nigolian H; Czarnetzki C; Harr T
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.